ArticleFrontiers in pharmacology2019

Novel 3,4-Dihydroisocoumarins Inhibit Human P-gp and BCRP in Multidrug Resistant Tumors and Demonstrate Substrate Inhibition of Yeast Pdr5.

Julia Sachs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.